Law MCQs

Chapter XIV's penalty architecture reveals a considered legislative approach: rather than a single blanket penalty, the various specific offences (general infringement, collection/compendium piracy, counterfeit sound/cinematographic copies, private-use exploitation, overproduction, unauthorized rental, false Register entries, false statements, false attribution) largely share a common core penalty range, while Section 70B's escalation mechanism specifically targets recidivism, and narrower/more preparatory offences like Section 67's plate possession carry a somewhat reduced maximum imprisonment term.

Section 3(g)(i) defines the core meaning of 'drug' broadly: 'any substance or mixture of substances that is manufactured, sold, stored, offered for sale or represented for internal or external use in the treatment, mitigation, prevention or diagnosis of disease, an abnormal physical state, or the symptoms thereof in human beings or animals, or the restoration, correction, or modification of organic functions in human beings or animals' — while excluding substances used exclusively in ayurvedic, unani, homoeopathic, or biochemic systems (except as separately prescribed).

The second proviso to Section 7 addresses a narrow category: 'in respect of any share obtained at par from the Federal Government by any directors of the Central Board of Directors of the State Bank or a member of the Local Board of that Bank under the provisions of sub-section (3) of section 13 of the State Bank of Pakistan Act, 1956... the amount of compensation shall be calculated at the rate of one hundred rupees per share' — a fixed, formula-based rate distinct from both the general break-up-value method and the State Bank's own stock-exchange-based method.

Section 18(1)(i) allows an Inspector to 'forbid for a reasonable period, not exceeding two weeks or such further period, which shall not be more than three months, as the Inspector may, with the approval of the Provincial Quality Control Board, the Central Licensing Board, the Registration Board or the licensing authority, as the case may be, specify, any person in charge of any premises from removing or dispensing of any drug, article or other thing likely to be used in evidence' — balancing evidentiary preservation needs against indefinite business disruption.

Section 3(r) defines 'manufacture' broadly to include 'processing, compounding, formulating, filling, packing, repacking, altering, ornamenting, finishing and labelling with a view to its storage, sale and distribution,' but explicitly carves out 'the compounding and dispensing or the packing of any drug in the ordinary course of retail business or on a prescription of a registered medical practitioner or dentist or of a veterinarian' — sparing ordinary pharmacists filling prescriptions from being classified as 'manufacturers' requiring a manufacturing licence.

Both regimes follow the same underlying legislative technique: a clean vesting of assets/rights/liabilities in a designated successor (the State Bank for the Council under Section 9(2); continued vesting in the bank itself, per Section 16(a), even as ownership shifts to the Federal Government under Section 5), coupled with preserved contractual force (Sections 9(4) and 16(b)) and preserved litigation continuity (Sections 9(5) and 16(c)) — a consistent statutory pattern for managing institutional transitions without disrupting third-party legal relationships.

Section 9 provides: 'No person shall be entitled to copyright or any similar right in any work, whether published or unpublished, otherwise than under and in accordance with the provisions of this Ordinance, or of any other law for the time being in force, but nothing in this section shall be construed as abrogating any right or jurisdiction to restrain a breach of trust or confidence' — establishing the Ordinance (plus other applicable law) as the exclusive source of copyright, while preserving the distinct equitable doctrine of breach of confidence.

Section 12(2) provides: copyright in a design 'capable of being registered under the Patents and Designs Act, 1911... but which has not been so registered, shall cease as soon as any article to which the design has been applied has been reproduced more than fifty times by an industrial process by the owner of the copyright or, with his licence, by any other person' — an incentive mechanism nudging designers toward the more appropriate design-registration regime once mass industrial production begins, rather than relying indefinitely on copyright.

Section 3(1)(a) defines one limb of 'bank' as 'a company registered under the Companies Act, 1913 (VII of 1913) and transacting, in or outside Pakistan, the business of banking as defined in clause (b) of section 5 of the Banking Companies Ordinance, 1962... in respect of which no proceedings under Part III or Part IV of the said Ordinance have been taken or are pending immediately before the commencing day.' This excludes banks already under a form of regulatory intervention (such as winding-up or moratorium proceedings) at the critical date.

Two distinct protective mechanisms could potentially apply here: Section 18's general good-faith indemnity (protecting the officer personally from suit/prosecution/damage-liability for good-faith acts under the Act), and separately, Section 5A(3)'s specific ouster clause barring challenges to the Federal Government's variation/modification/annulment of sale terms 'on any ground whatsoever' — together reflecting the Act's broader pattern of shielding good-faith implementation of its privatization and nationalization mechanisms from litigation.